Table 1 Clinical characteristics of 80 gastric cancer patients and AURKA/p27 expression
| Â | Â | Aurora A and p27 expression | P | ||
|---|---|---|---|---|---|
| Â | Â | 2H | 1H1L | 2L | |
Sex | |||||
  Male | 63 | 54 | 7 | 2 | 0.191 |
  Female | 17 | 15 | 2 | 0 | |
Age (years) | |||||
  <60 | 27 | 22 | 5 | 0 | 0.071 |
  >=60 | 53 | 47 | 6 | 0 | |
Tumor volume (cm3) | |||||
  <=5 | 46 | 40 | 6 | 0 | 0.203 |
  >5 | 34 | 29 | 3 | 2 | |
Tumor location | |||||
  Up | 19 | 15 | 4 | 0 | 0.687 |
  Middle | 22 | 19 | 3 | 0 | |
  Down | 39 | 35 | 4 | 0 | |
Pathological grade | |||||
  II | 26 | 20 | 6 | 0 | 0.991 |
  II–III | 25 | 25 | 0 | 0 | |
  III | 29 | 24 | 3 | 2 | |
Invasion stage | |||||
  Mucosal and submucosal | 1 | 1 | 0 | 0 | 0.372 |
  Muscular layer | 8 | 7 | 1 | 0 | |
  Serous membrane and outmembrane | 71 | 61 | 8 | 2 | |
Lymph node metastasis | |||||
  0 | 17 | 16 | 1 | 0 | 0.510 |
  1–6 | 36 | 29 | 7 | 0 | |
  >=7 | 27 | 24 | 3 | 0 | |
TNM stage | |||||
  I | 5 | 5 | 0 | 0 | 0.031 |
  II | 22 | 19 | 3 | 0 | |
  III | 46 | 41 | 3 | 2 | |
  IV | 7 | 4 | 3 | 0 | |
Total | 80 | Â | Â | Â | 80 |